Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rakesh Heer

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Trials|March 21, 2026
PARTIAL: study protocol for a clinical and cost-effectiveness of complex PARTIAL vs radical nephrectomy for clinically localised renal cell carcinoma randomised trialDiana Johnson, Ruth Thomas, Seonaidh Cotton, et al.
Nature Communications|December 11, 2024
AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patientsTodd P Knutson, Bin Luo, Anna Kobilka, et al.
Ebiomedicine|October 25, 2025
Detection of urothelial carcinoma in Lynch syndrome using microsatellite instability analysis of urine cell-free DNARebecca Hall, Richard Gallon, Christine Hayes, et al.
Scientific Reports|October 9, 2023
The role of GCNT1 mediated O-glycosylation in aggressive prostate cancerKirsty Hodgson, Margarita Orozco-Moreno, Emma Scott, et al.
NIHR Open Research|October 25, 2023
Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trialPaul Gravestock, Emma Clark, Miranda Morton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2026
Evolution of AR and non-AR alterations in circulating tumor DNA of metastatic prostate cancer patients treated in the phase 3 Alliance A031201 trialJosé C Valentín López, Chenxi Yu, Todd P Knutson, et al.
Contemporary Clinical Trials|June 8, 2025
Prostate Assessment using Comparative Interventions - Fast MRI and Image-fusion for Cancer (IP7-PACIFIC): A prospective, multi-centre, dual sequential randomised controlled trialNikhil Mayor, Alexander Light, Francesca Rawlins, et al.
BMJ Open|September 5, 2019
Photodynamic versus white light-guided treatment of non-muscle invasive bladder cancer: a study protocol for a randomised trial of clinical and cost-effectivenessZafer Tandogdu, Rebecca Lewis, Anne Duncan, et al.
The Journal of Clinical Investigation|September 26, 2023
The catalytic subunit of DNA-PK regulates transcription and splicing of AR in advanced prostate cancerBeth Adamson, Nicholas Brittain, Laura Walker, et al.
Communications Biology|March 6, 2024
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancerRebecca Garnham, Daniel Geh, Ryan Nelson, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Trials|March 21, 2026
PARTIAL: study protocol for a clinical and cost-effectiveness of complex PARTIAL vs radical nephrectomy for clinically localised renal cell carcinoma randomised trialDiana Johnson, Ruth Thomas, Seonaidh Cotton, et al.
Nature Communications|December 11, 2024
AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patientsTodd P Knutson, Bin Luo, Anna Kobilka, et al.
Ebiomedicine|October 25, 2025
Detection of urothelial carcinoma in Lynch syndrome using microsatellite instability analysis of urine cell-free DNARebecca Hall, Richard Gallon, Christine Hayes, et al.
Scientific Reports|October 9, 2023
The role of GCNT1 mediated O-glycosylation in aggressive prostate cancerKirsty Hodgson, Margarita Orozco-Moreno, Emma Scott, et al.
NIHR Open Research|October 25, 2023
Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trialPaul Gravestock, Emma Clark, Miranda Morton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2026
Evolution of AR and non-AR alterations in circulating tumor DNA of metastatic prostate cancer patients treated in the phase 3 Alliance A031201 trialJosé C Valentín López, Chenxi Yu, Todd P Knutson, et al.
Contemporary Clinical Trials|June 8, 2025
Prostate Assessment using Comparative Interventions - Fast MRI and Image-fusion for Cancer (IP7-PACIFIC): A prospective, multi-centre, dual sequential randomised controlled trialNikhil Mayor, Alexander Light, Francesca Rawlins, et al.
BMJ Open|September 5, 2019
Photodynamic versus white light-guided treatment of non-muscle invasive bladder cancer: a study protocol for a randomised trial of clinical and cost-effectivenessZafer Tandogdu, Rebecca Lewis, Anne Duncan, et al.
The Journal of Clinical Investigation|September 26, 2023
The catalytic subunit of DNA-PK regulates transcription and splicing of AR in advanced prostate cancerBeth Adamson, Nicholas Brittain, Laura Walker, et al.
Communications Biology|March 6, 2024
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancerRebecca Garnham, Daniel Geh, Ryan Nelson, et al.
Pageof 8